Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Friday, November 22, 2024

Many Antidepressants Tied To Higher Dementia Risk, Large Study Finds

 Demand your competent? doctor give you 100% recovery protocols so anti-depressants aren't needed!

Many Antidepressants Tied To Higher Dementia Risk, Large Study Finds

Safer alternatives should be considered by doctors, the researchers advise.(LIKE MAYBE 100% RECOVERY WHICH SURVIVORS HAVE BEEN CLAMORING FOR AND YOUR STROKE MEDICAL 'PROFESSIONALS' HAVE BEEN IGNORING!)

Antidepressants that have an anticholinergic effect are linked to an increased risk of dementia, research finds.

Anticholinergic antidepressants include drugs such as Amitriptyline (known as Elavil), Dosulepin and Paroxetine (known as Paxil and Seroxat).

(A longer list of drugs is at the bottom of this article.)

Although often older, many millions of people still take these type of antidepressants.

The longer people take these drugs, the researchers found, the higher their risk of dementia.

More modern antidepressants, like Prozac and Xanax, generally have a lower anticholinergic effect, and were not linked to a higher dementia risk.

Dr George Savva, who led the study, said:

“We studied patients with a new dementia diagnosis and looked at what anticholinergic medication they were prescribed between four and 20 years prior to being diagnosed.

We found that people who had been diagnosed with dementia were up to 30 per cent more likely to have been prescribed specific classes of anticholinergic medications.

And the association with dementia increases with greater exposure to these types of medication.

What we don’t know for sure is whether the medication is the cause.

It could be that these medications are being prescribed for very early symptoms indicating the onset of dementia.

But because our research shows that the link goes back up to 15 or 20 years before someone is eventually diagnosed with dementia, it suggests that reverse causation, or confounding with early dementia symptoms, probably isn’t the case.

The conclusions come from the medical records of 40,770 patients aged over 65 who were diagnosed with dementia.

These were compared to 283,933 without dementia.

The results showed the link between dementia and anticholinergic drugs.

Other common anticholinergic drugs also linked to dementia include those prescribed for bladder conditions and Parkinson’s (e.g. Tolterodine, Oxybutynin, Solifenacin and Procyclidine).

No link, though, was found between antihistamines (used to treat allergies) and dementia, as previous research had.

Dr Noll Campbell, study co-author, said:

“These results suggest we should prioritise safer alternatives to anticholinergic medications long before symptoms of dementia are recognised.”

Professor Chris Fox, study co-author, said:

“Doctors and patients should therefore be vigilant about using anticholinergic medications.

They need to consider the risk of long-term cognitive effects, as well as short-term effects, associated with specific drugs when weighing up risks and benefits.

We don’t know exactly how anticholinergics might cause dementia.

Further research is needed to understand possible reasons for this link.

In the meantime, I strongly advise patients with any concerns to continue taking their medicines until they have consulted their doctor or pharmacist.”

Here are some common drugs that have a definite anticholinergic effect:

  • Amitriptylline
  • Brompheniramine
  • Chlorpheniramine
  • Clomipramine
  • Clozapine
  • Dimenhydrinate
  • Diphenhydramine
  • Hydroxyzine
  • Paroxetine
  • Promethazine

These drugs also have an anticholinergic effect, although it is lower than the list above:

  • Amantadine
  • Belladona
  • Cyclobenzaprine
  • Cyproheptadine
  • Carbamazepine
  • Loxapine
  • Meperidine
  • Molindone
  • Oxcarbazine
  • Pimozide

These drugs may have an anticholinergic effect:

  • Alprazolam
  • Atenolol
  • Captopril
  • Codeine
  • Diazepam
  • Digoxin
  • Furosemide
  • Prednisone
  • Nifedipine
  • Warfarin

Note that this is not a complete list of drugs and it only contains the drug names not the brand names under which each is sold.


The study was published in the journal BMJ (Richardson et al., 2018).

No comments:

Post a Comment